DIANA N KESSLER

Allopathic & Osteopathic Physicians|Emergency Medicine DAYTON, TN NPI 1295701795

General Payments — all program years on this page

$342.43

  • Category: General Payments
  • Program years: PY2024
  • Record count: 19
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $342.43 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $342.4319

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $155.888
Lilly USA, LLC $55.073
ABBVIE INC. $30.312
PFIZER INC. $20.821
Vanda Pharmaceuticals Inc. $18.401
GlaxoSmithKline, LLC. $17.751
Exact Sciences Corporation $15.121
ITI, Inc. $14.671
Amgen Inc. $14.411

By program year

Program yearAmountRecords
2024 $342.4319

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096599929 Novo Nordisk Inc $27.55 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096828669 Novo Nordisk Inc $16.64 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096829223 Novo Nordisk Inc $22.30 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096907223 Novo Nordisk Inc $0.66 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097157493 Novo Nordisk Inc $17.76 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097267878 Novo Nordisk Inc $30.21 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097741484 Novo Nordisk Inc $23.24 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097784882 Novo Nordisk Inc $17.52 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104055776 ABBVIE INC. $14.45 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104055778 ABBVIE INC. $15.86 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111617672 Amgen Inc. $14.41 07/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114535552 Exact Sciences Corporation $15.12 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116603422 GlaxoSmithKline, LLC. $17.75 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131459368 PFIZER INC. $20.82 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133908619 Vanda Pharmaceuticals Inc. $18.40 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136142579 Lilly USA, LLC $20.31 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136145777 Lilly USA, LLC $21.48 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136157761 Lilly USA, LLC $13.28 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143255842 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.67 09/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.